Background: In 2012, the United States Preventive Services Task Force (USPSTF) recommended against prostate-specific antigen (PSA)-based prostate cancer screening for all men.
| INTRODUCTION
Because cancer screening is one important approach to reducing cancer-related morbidity and mortality, decades of effort have been exerted explicitly to promote cancer screening behaviours. However, there is a growing appreciation of the potential harms associated with screening and the fact that the overall balance of benefits vs harms (ie screening value) may be less pronounced than originally thought. 1, 2 In particular, there is increasing recognition that for some (especially the elderly or those with life-limiting comorbidities), the harms of screening outweigh the benefits. 3 Concerns about the unfavourable balance of benefits and harms are particularly pronounced for prostate cancer screening. In its 2012 recommendation statement for prostate cancer screening, the United States Preventive Services Task Force (USPSTF) recommended against prostate-specific antigen (PSA)-based prostate cancer screening for all men, because it concluded from the available evidence that the very low probability of preventing a death from prostate cancer in the long term (1 in 1000 men screened or less) does not outweigh the moderate-to-high probability of early and persistent harms. 4 The harms of PSA screening and subsequent diagnostic tests and treatments can be serious and include the following: anxiety about test results, 5, 6 hospitalizations resulting primarily from resistant E. Coli infections following trans-rectal prostate biopsies (experienced by 1-2 in 1000 men screened); 4,7 serious cardiovascular events following prostatectomy (experienced by 3 in 1000 men screened); 4 and erectile, urinary and bowel dysfunction following surgery and other prostate cancer treatments (experienced by 35 in 1000 men screened).
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The USPSTF statement recommending against PSA screening spurred considerable debate among experts, [9] [10] [11] [12] and a nationally representative survey of men aged 40-74 conducted shortly after the draft recommendations were published found that, while the majority (62%) agreed with the recommendation, few (13%) intended to follow it.
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Despite the controversy surrounding the USPSTF prostate cancer screening recommendations, national data from the year following their release documenting modest but statistically significant declines in PSA screening in every age group suggest that at least some patients and providers are receptive to discontinuing screening. 14, 15 we stratified our study sample by race (African American; non-African American), age (50-69; 70-84) and PSA level (documentation of a PSA level ≥4 in VHA electronic medical records vs no such documentation), as shown in Table 1 .
From the 11 543 patients meeting eligibility criteria, we randomly selected 150 to recruit to the individual interviews (25 per strata in Table 1 ). We mailed these 150 eligible individuals a letter describing the study, and alerting them to the fact that a VA employee might call them in the next few weeks to see whether they would be interested in participating in an interview. The letter included a phone number and email address to contact whether the Veteran preferred not to be called. We then proceeded to call Veterans who did not opt out of the study (n=150), until we recruited five participants within each stratum (or 30 overall). We scheduled Veterans agreeing to participate for one-hour individual interview slots. We offered Veterans who completed interviews $40 compensation for their time and travel expenses.
Because we used our findings to develop educational materials needed within a constrained timeline, we determined sample size a priori, based both on expert recommendations for minimum qualitative sample sizes 20 and on resource availability within the pre-specified timeline. Based on the findings of one prior study documenting that 90% of high-frequency themes were identified after six interviews, 21 we sought to obtain 6-10 completed interviews in each subgroup of interest: age (50-59, 70-84), race (African American, non-African American) and PSA level (elevated, not elevated). We completed 10-16 interviews in each of these subgroups and conducted post hoc descriptive analyses of code saturation (described below) to assess whether these sample sizes were sufficient to identify high-frequency themes. We did not stratify the African American sample by age due to the small number of African American men over the age of 70 in the sampling frame, but did complete interviews with two African
American men aged 70-84. 
| Data collection

| Analysis
We recorded and transcribed all interviews and imported the transcribed data into qualitative software (NVIVO 10) for coding and analysis. We did not return transcripts to participants for comment or correction. Our inductive analysis approach was informed by grounded theory 22 (ie codes and themes were identified emergently from the text rather than applied from pre-existing frameworks or theories). We used this inductive approach rather than a deductive approach applying codes from the Preventive Health Model or other framework because, at the time the study was conducted, little was known about men's perceptions regarding prostate cancer screening benefits, harms, or new recommendations against screening. Our objective was therefore to characterize these perceptions to inform hypotheses to test in future quantitative studies. Our inductive coding and analysis approach involved several steps. In the first step, one investigator developed a provisional codebook based on the interview guide. In the second step, this investigator and a second coder independently reviewed transcripts in batches of 5-8.
For each batch, coders noted concepts emerging from the text, met to discuss emergent concepts and agree on conceptual categories, added agreed upon categories and examples to an evolving codebook, and then applied the codebook to the transcripts reviewed (see Table 2 for final coding tree). To facilitate the post hoc saturation analyses described below, we coded transcripts in the order in which the interviews were completed. In the third step, the two coders used the coding comparison feature in NVIVO to identify coding discrepancies, and then adjudicated all differences to arrive at final coding decisions for analysis. In the last step, the coders identified major themes and then compared the range and frequency of these themes across race, age and PSA level subgroups.
To provide insights into potential theme saturation, we examined the number and per cent of all themes and high-frequency themes (mentioned by more than 25% of the sample) included in our final codebook that were identified after each batch of interviews coded.
The study protocol was reviewed and approved by the Institutional Review Boards at the Minneapolis VA Health Care System and the University of Minnesota.
| RESULTS
| Participant demographic characteristics
We scheduled interviews with 30 individuals and completed inter- men with a prior elevated PSA and 13 men without a prior elevated PSA (Table 3) .
| Perceptions about benefits
When asked their perspectives on the potential benefits of screening, most men mentioned a physical benefit. The most common physical benefit mentioned in every subgroup was early detection and/or prevention of disease progression. Finally, a few non-African American men from both age groups without a prior elevated PSA mentioned being proactive or doing something to stay on top of one's health as a benefit of screening. 
| Reactions to recommendations against screening
When asked what they thought about new guidelines recommending against prostate cancer screening, at least five men in every subgroup expressed unconditional receptivity to the idea of discontinuing PSA. When later asked how they would react if their own provider recommended they stop screening, these same men said: The above difference in expressed uncertainty aside, our results suggest that perceptions and reactions were similar across all subgroups examined. All high-frequency themes (mentioned by at least 25% of participants) were mentioned by every subgroup.
"I think that it's a step in the right direction, really. There's no hesitation at all on my part to accept this, and I think it just makes a lot of sense." (ID #1041 -non-African
"I'd
| Saturation analysis
Our final codebook (Table 2 ) included 37 unique codes. Our saturation analysis revealed that we identified 92% of all codes and 100% of high-frequency codes (ie those mentioned by more than 25% of participants) in the first five interviews completed. The only codes not identified in the first five interviews were two low-frequency codes (mentioned by less than 25% of participants): small benefit and harms/ physical/problems with urination. While materials targeted by race, age or PSA level may not be necessary, materials that address the misperceptions about benefits and lack of awareness of potential harms expressed in all subgroups are clearly needed. Although PSA-based prostate cancer screening has not been shown to reduce overall mortality, and any reductions in prostate cancer specific mortality are judged to be small (1 in 1000 or less) through at least 10-15 years, 4 some men in every subgroup thought PSA screening could help them live longer and perceived the chance of experiencing this benefit to be high. Only one individual in our sample seemed aware that the mortality reduction from PSA screening was small. Additionally, we found that most men in every subgroup had difficulty connecting PSA screening with any harms. [31] [32] [33] [34] [35] Our study has a number of strengths, including the rigorous coding approach, saturation analysis and comparison of perceptions and reactions across race, age and prior PSA result subgroups. However, our findings should be qualified by the following limitations. First, because this was a qualitative study, we cannot determine whether the prevalence or salience of certain perceptions and reactions varies significantly across the demographic and prior experience subgroups included in our study. Second, because our sample size was determined a priori rather than by saturation, we cannot be certain that all key themes were identified in our sample of 26 individuals. However, the findings from our post hoc saturation analysis provide reassur- 
| DISCUSSION
| CONCLUSIONS
Our findings suggest a similar range of reactions to new prostate cancer screening guidelines regardless of race, age or prior PSA screening. test whether motivation to discontinue screening varies significantly across these subgroups; and quantify the effect of a physician recommendation to discontinue PSA screening on future screening intentions.
